nipradilol has been researched along with Cranial Nerve II Injuries in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishida, K; Karim, MZ; Kawakami, H; Mizuno, K; Sawada, A; Yamamoto, T | 1 |
Tokita, Y; Watanabe, M; Yata, T | 1 |
Nakamura, M; Sagawa, H; Terasaki, H; Tokita, Y; Watanabe, M; Yata, T | 1 |
3 other study(ies) available for nipradilol and Cranial Nerve II Injuries
Article | Year |
---|---|
Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Cell Count; Cell Survival; Disease Models, Animal; Intraocular Pressure; Male; Nerve Degeneration; Neuroprotective Agents; Optic Nerve Injuries; Propanolamines; Rats; Rats, Wistar; Retinal Ganglion Cells | 2009 |
Axonal regeneration of cat retinal ganglion cells is promoted by nipradilol, an anti-glaucoma drug.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cats; Graft Survival; Nerve Growth Factors; Nerve Regeneration; Neuroprotective Agents; Nitric Oxide Donors; Optic Nerve; Optic Nerve Injuries; Peripheral Nerves; Propanolamines; Receptors, Adrenergic; Retinal Ganglion Cells | 2006 |
Survival and axonal regeneration of off-center retinal ganglion cells of adult cats are promoted with an anti-glaucoma drug, nipradilol, but not BDNF and CNTF.
Topics: Age Factors; Animals; Antihypertensive Agents; Axons; Brain-Derived Neurotrophic Factor; Cats; Cell Count; Cell Shape; Cell Survival; Ciliary Neurotrophic Factor; Ciliary Neurotrophic Factor Receptor alpha Subunit; Dendrites; Denervation; Glaucoma; Graft Survival; Nerve Regeneration; Optic Nerve Injuries; Propanolamines; Receptor, trkB; Recovery of Function; Retinal Ganglion Cells | 2007 |